PlainPharmaWatch

CMS Open Payments · Tool

Vapotherm Inc vs Haag-Streit USA, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Haag-Streit USA, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 4,605, versus 783 for the other company. Its single largest recorded recipient represents 0.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Vapotherm Inc
HHI 783 · top recipient 0.1%
Ranked #1,126 of 1,838 companies by HHI
Haag-Streit USA, Inc.
HHI 4,605 · top recipient 0.7%
Ranked #399 of 1,838 companies by HHI

Payment Overview

Company A

Vapotherm Inc

Total Payments
$195.6K
% of Industry
0.0%
Transactions
376
Avg per Transaction
$520.18
Recipients
375
Avg per Recipient
$521.57
Payment Types
6
Top Payment Type
Long-Term Medical Supply or Device Loan
Total Payments
$195.6K
% of Industry
0.0%
Transactions
400
Avg per Transaction
$489.07
Recipients
400
Avg per Recipient
$489.07
Payment Types
6
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Vapotherm Inc vs Haag-Streit USA, Inc. - total reported payments in CMS Open Payments PY2024

Haag-Streit USA, Inc.$195.6KVapotherm Inc$195.6K

Payment Types Breakdown

Vapotherm Inc

Long-Term Medical Supply or Device Loan $85.9K

43.9%

Consulting Fee $31.6K

16.2%

Food and Beverage $12.9K

6.6%

Travel and Lodging $4.8K

2.5%

Grant $500.00

0.3%

Education $31.50

0.0%

Haag-Streit USA, Inc.

Consulting Fee $125.5K

64.1%

Royalty or License $49.5K

25.3%

Compensation for Services Other Than Consulting $12.6K

6.4%

Food and Beverage $5.0K

2.5%

Gift $2.6K

1.3%

Travel and Lodging $490.27

0.3%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Vapotherm Inc

  1. 1

    ERLANGER MEDICAL CENTER

    $16,451.23 · 1 txns

  2. 2

    UNIVERSITY MEDICAL CENTER

    $15,124.52 · 1 txns

  3. 3

    LOMA LINDA UNIVERSITY MEDICAL CENTER

    $14,806.11 · 1 txns

  4. 4

    BAPTIST HEALTH MEDICAL CENTER - LR

    $14,063.15 · 1 txns

  5. 5

    COXHEALTH

    $13,716.00 · 1 txns

Haag-Streit USA, Inc.

  1. 1

    WARREN HILL

    $130,121.03 · 16 txns

  2. 2

    MICHAEL SNYDER

    $16,515.71 · 49 txns

  3. 3

    Samuel Masket

    $12,760.00 · 1 txns

  4. 4

    MICHAEL LYONS

    $11,581.31 · 225 txns

  5. 5

    AMY ZHANG

    $9,162.46 · 36 txns

Summary Comparison

Metric Vapotherm Inc Haag-Streit USA, Inc.
Total Payments $195.6K $195.6K
% of Industry Total 0.0% 0.0%
Transaction Count 376 400
Avg per Transaction $520.18 $489.07
Recipient Count 375 400
Avg per Recipient $521.57 $489.07
Payment Type Count 6 6
Top Payment Type Long-Term Medical Supply or Device Loan Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.